The LDIflare: A novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes

Diabetes Care

Volumn 27, Issue 12, 2004, Pages 2930-2935

  Krishnan, Singhan T M ^a   Rayman, Gerry ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HEATING; HUMAN; LASER DOPPLER FLOWMETRY; MALE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE;

BODY MASS INDEX; BRACHIAL PLEXUS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PRESSURE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 9444282007     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.12.2930     Document Type: Article

References (58)

1. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Fach JM, Wilson DM, PC OB, Melton LJ, Service FJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993 [erratum in Neurology 43:2345, 1993]
2. Young MJ, Boulton AJ, Macleod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150-154, 1993
3. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu Tirgoviste C, Nuber A, Pozza G, Ward JD: Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39:1377-1384, 1996
4. Galer BS, Gianas A, Jensen MP: Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47:123-128, 2000
5. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RF: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 18:216-219, 1995
6. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13:513-521, 1990
7. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ: Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10:432-440, 1987
8. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384, 2002
9. Paisley AN, Abbott C, van Schie C, Boulton AJM: A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabet Med 19:400-405, 2002
10. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ: Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21:1071-1075, 1998
11. Kastenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K: A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc 91:343-350, 2001
12. Young MJ, Breddy JL, Veyes A, Boulton AJ: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care 17:557-560, 1994
13. Boulton AJ, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM, Skyler JS, Sosenko JM: Impaired vibratory perception and diabetic foot ulceration. Diabet Med 3:335-337, 1986
14. Ziegler D, Mayer P, Gries FA: Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry 51:1420-1424, 1988
15. Ziegler D, Mayer P, Wiefels K, Gries FA: Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 34:1-10, 1988
16. Levitt NS, Stansberry KB, Wynchank S, Vinik AI: The natural progression of autonomie neuropathy and autonomie function tests in a cohort of people with IDDM. Diabetes Care 19:751-754, 1996
17. Vinik AI, Park TS, Stansberry KB, Pittenger GL: Diabetic neuropathies. Diabetologia 43:957-973, 2000
18. Celiker R, Basgoze O, Bayraktar M: Early detection of neurological involvement in diabetes mellitus. Electromyogr Clin Neurophysiol 36:29-35, 1996
19. Vinik Al, Erbas T, Stansberry KB, Pittenger GL: Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 109:451-473, 2001
20. Singleton JR, Smith AG, Bromberg MB: Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24:1448-1453, 2001
21. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225-1228, 2001
22. Smith AG, Ramachandran P, Tripp S, Singleton JR: Epidermal nerve innervation in Impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704, 2001
23. Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S, Sima AA: Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabete Metab Res Rev 18:473-483, 2002
24. Ali Z, Carroll M, Robertson KP, Fowler CJ: The extent of small fibre sensory neuropathy in diabetics with plantar foot ulceration. J Neurol Neurosurg Psychiatry 52:94-98, 1989
25. Sosenko JM, Kato M, Soto R, Bild DE: Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 13:1057-1061, 1990
26. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL: A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 43:1508-1512, 1993
27. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O'Brien PC: A standard test of heat-pain responses using CASE IV. J Neurol Sci 136:54-63, 1996
28. Gruener G, Dyck PJ: Quantitative sensory testing: methodology, applications, and future directions. J Clin Neurophysiol 11:568-583, 1994
29. Shy ME, Frohman EM, So YT, Arezzo JC, Comblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH: Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60:898-904, 2003
30. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman JS, Kelsey SF, Becker DJ, Orchard TJ: Measuring diabetic neuropathy: assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12:270-275, 1989
31. Freeman R, Chase KP, Risk MR: Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 60:465-470, 2003
32. Gelber DA, Pfeifer MA, Broadstone VL, Munster EW, Peterson M, Arezzo JC, Shamoon H, Zeidler A, Clements R, Greene DA, Porte D, Laudadio C, Bril V: Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects. J Diabetes Complications 9:170-176, 1995
33. Lindberger M, Schroder HD, Schultzberg M, Kristensson K, Persson A, Ostman J, Link H: Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci 93:289-296, 1989
34. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC: Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy: Neurology 45:1848-1855, 1995
35. Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC: Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 48:708-711, 1997
36. Hirai A, Yasuda H, Joko M, Maeda T, Kikkawa R: Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J Neurol Sci 172:55-62, 2000
37. Griffin JW, McArthur JC, Polydefkis M: Assessment of cutaneous innervation by skin biopsies. Curr Opin Neurol 14:655-659, 2001
38. Polydefkis M, Hauer P, Griffin JW, McArthur JC: Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 3:23-28, 2001
39. Hutchison KJ, Johnson BW, Williams HT, Brown GD: The histamine flare response in diabetes mellitus. Surg Gynecol Obstet 139:566-568, 1974
40. Aronin N, Leeman SE, Clements RS Jr: Diminished flare response in neuropathic diabetic patients: comparison of effects of substance P, histamine, and capsaicin. Diabetes 36:1139-1143, 1987
41. Walmsley D, Wiles PG: Early loss of neurogenic inflammation in the human diabetic foot. Clin Sci (Colch) 80:605-610, 1991
42. Walmsley D, Wales JK, Wiles PG: Reduced hyperaemia following skin trauma: evidence for an impaired microvascular response to injury in the diabetic foot. Diabetologia 32:736-739, 1989
43. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, Handwerker HO: Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 11:645-648, 2000
44. Walmsley D, Wiles PG: Assessment of the neurogenic flare response as a measure of nociceptor C fibre function. J Med Eng Technol 14:194-196, 1990
45. Caselli A, Rich J, Hanane T, Uccioli L, Veves A: Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology 60:297-300, 2003
46. Parkhouse N, Le Quesne PM: Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 318:1306-1309, 1988
47. Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE, Hassan A: Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. BMJ (Clin Res Ed) 292:1295-1298, 1986
48. Wiles PG, Pearce SM, Rice PJ, Mitchell JM: Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet Med 8:157-161, 1991
49. Dyck PJ, Zimmerman IR, PC OB, Ness A, Caskey PE, Karnes J, Bushek W: Introduction of automated systems to evaluate touch-pressure, vibration, and thermal cutaneous sensation in man. Ann Neurol 4:502-510, 1978
50. Benarroch EE, Low PA: The acetylcholine-induced flare response in evaluation of small fiber dysfunction. Ann Neurol 29:590-595, 1991
51. Berg TJ, Levy DM, Reid G, Abraham RR: The effects of vasoactive intestinal polypeptide and substance P on methacholine-induced sweating and vascular flare in diabetic neuropathy. Clin Auton Res 5:159-164, 1995
52. Durand S, Fromy B, Bouy P, Saumet JL, Abraham P: Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms. J Vasc Res 39:59-71, 2002
53. Droog EJ, Sjoberg F: Nonspecific vasodilatation during transdermal iontophoresis: the effect of voltage over the skin. Microvasc Res 65:172-178, 2003
54. Treede RD: Vasodilator flare due to activation of superficial cutaneous afferents in humans: heat-sensitive versus histamine-sensitive fibers. Neurosci Lett 141:169-172, 1992
55. Krishnan ST, Baker NR, Carrington AL, Rayman G: Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes. Diabetes Care 27:1343-1348, 2004
56. Rayman G, Malik RA, Sharma AK, Day JL: Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients. Clin Sci (Colch) 89:467-474, 1995
57. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47:457-463, 1998
58. Vinik AI, Erbas T, Park TS, Stansberry KB, Scanelli JA, Pittenger GL: Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 24:1468-1475, 2001